$PACS

Jergensen Joshua sold $1.7M of PACS

Jergensen Joshua (President & COO) sold 40,000 shares of PACS Group, Inc. (PACS) at an average of $43.13 ($43.08–$43.62, $1.73M total) across 2 trades on 2026-09-16 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Jergensen Joshua
Published Sep 17, 2026, 10:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 10:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PACS
Neutral
medium confidence
Mentioned
$PACS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PACSNeutralLow
01

Why it matters

Insider sale of $1.7M may slightly affect short‑term sentiment but unlikely to drive price.

02

Market read

A modest insider sell; traders may monitor for any follow‑up activity.

03

What to watch

Potential upcoming corporate actions or personal liquidity needs not disclosed.

Relevance 5/10Novelty 4/10Timing: post‑market 2026‑09‑16 filing

Background

SEC Form 4 filing provides primary source disclosure of insider transactions.

Company-level read

Ticker impact

$PACSNeutralMedium confidence
Context

Form 4 disclosed President & COO sold $1.7M of shares via 10b5‑1 plan.

Expected impact

Potential slight downward pressure; unlikely to move price materially.

Evidence & confidence

Sale represents ~0.07% of total shares; typical for diversification, limited impact.

Market effects

Minimal effect on healthcare services sector; no broader trend indicated.

Limited to US markets where PACS trades.

Low; isolated insider transaction.

Counterpoint

Sale could be routine diversification rather than a negative signal.

Key entities

  • PACS Group, Inc.

    Healthcare services provider listed on NYSE under ticker PACS.

  • Jergensen Joshua

    President & COO of PACS, reporting the insider sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PACSHighAI 8/10

Why is PACS stock rallying today?

PACS stock rose 3.3% premarket after announcing two growth initiatives: acquiring 32 Florida nursing facilities and closing 11 more from the Eduro Healthcare deal, expanding its network to 355 buildings. The company's stock has recovered from a 52-week low of $7.50, now trading at $43.52. PACS's low leverage and favorable Medicare reimbursements support its growth strategy.

$PACSMed

PACS Group stock rises on Florida expansion, Eduro closings

PACS Group (NYSE:PACS) shares rose 3.3% premarket after announcing plans to acquire 32 Florida skilled nursing facilities, adding 4,049 beds. The deal, expected to close Q4, expands PACS's southern footprint. Additionally, PACS completed closings on 11 more Eduro Healthcare facilities, bringing total Eduro closings to 31 of 34. The company now operates 355 facilities across 7 states. CEO Jason Murray highlighted Florida's growth potential.

$PACSHigh

PACS Group, Inc. (PACS): Results of Operations and Financial Condition

PACS Group, Inc. (PACS) filed an SEC Form 8-K — Results of Operations and Financial Condition. PACS Group, Inc. Reports Second Quarter 2026 Results Conference Call and Webcast Scheduled for Tomorrow, August 5, 2026, at 11:30 am ET. SALT LAKE CITY, Utah, August 4, 2026 – PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of

$PACSMedAI 8/10

Shearwater Group Contract Extension Worth £25m Lifts AIM Shares 17.6%

Shearwater Group said it secured a five-year £25m contract extension with a UK telecoms client, covering packet monitoring and forensic services. £12.5m is to be recognised in 2025-26, but cash is expected after year end; net cash is forecast at £5.6m and pre-tax profit at £1.1m. Shares rose 17.6% to 43.5p. Polar Capital and Supreme also moved on results.